ARROW PHARMA ApS
APSDissolvedCVR 25540417Ørnegårdsvej 16, 2820 GentofteWholesale of pharmaceutical and medical goods· NACE 4646Est. 2000 · 26 years old— employees
Loading company…
Riskpilot← Back to searchSign inGet full accessARROW PHARMA ApS is a Danish APS based in Gentofte, operating in the Wholesale of pharmaceutical and medical goods sector. Incorporated in 2000, the company reported a gross profit of DKK 999.0k in its latest annual filing.
| Gross profit | 1M DKK | -79% |
| EBITDA | 0.2M DKK | +115% |
| Net profit | 0.3M DKK | +119% |
| Total assets | 1.6M DKK | -90% |
| Equity | -13.3M DKK | +3% |
| Employees | — | — |
In its most recent annual report (2013), ARROW PHARMA ApS reported a gross profit of DKK 999.0k, a decrease of 79% on the year before. The figures on this page draw on 2 annual filings covering 2012 to 2013. The bottom line showed a net profit of DKK 343.8k, and the EBITDA margin stood at 22.3%.
At the end of 2013, current assets covered short-term debt 0.1 times.
| Item | 2013 | 2012 |
|---|---|---|
| Gross profit | 999 | 4,813 |
| Staff expenses | -777 | -628 |
| EBITDA | 222 | -1,439 |
| Depreciation & amort. | -0 | -0 |
| EBIT | 222 | -1,439 |
| Net financials | -104 | -366 |
| Profit before tax | 118 | -1,805 |
| Tax | -225 | -0 |
| Net profit | 344 | -1,805 |
| Item | 2013 | 2012 |
|---|---|---|
| Total assets | 1,581 | 15,403 |
| Equity | -13,293 | -13,637 |
| Long-term debt | 0 | 0 |
| Short-term debt | 14,874 | 29,040 |
| Total debt | 14,874 | 29,040 |
28 financial ratios from the latest filing, each graded against companies in the same industry.
Net profit as a percentage of total assets — the return generated on the capital employed.
EBIT relative to total assets — the company's earning power before the effects of tax and financial leverage.
Shows how strongly fixed costs weigh on the gross result — a high ratio means fixed costs take only a small bite out of the earnings from basic operations.
The gross result as a share of revenue — how much of the revenue is left after variable costs to cover the company's fixed costs.
EBIT as a share of revenue — the share of revenue remaining as earnings once all operating costs are covered. A key measure of earning power.
The profit for the year as a share of revenue — the company's ability to turn revenue into profit.
Net profit as a percentage of equity — the return the owners earned on their invested capital this year.
Profit relative to net assets (total assets minus total debt) — the ability to generate earnings from the net asset base alone.
Current assets relative to short-term debt — the ability to settle short-term obligations with current assets alone. Around 150% is considered satisfactory from a credit perspective.
Current assets excluding inventory relative to short-term debt — whether the most liquid assets alone can cover the short-term obligations. A value of 1 or above signals a healthy liquidity position.
Cash relative to short-term debt — the ability to repay short-term obligations with cash alone.
Cash flow relative to profit — the ability to convert reported profits into accessible cash.
Current assets relative to equity — an indicator of the balance-sheet structure and of the company's short- and long-term financing. The healthy level is highly industry-dependent.
Fixed assets relative to long-term capital (equity plus long-term liabilities). Below 100% means the long-term capital finances more than just the fixed assets — a healthier liquidity position.
Equity as a share of total assets — the ability to absorb losses. Around 40% is considered satisfactory from a credit perspective.
Total debt relative to the balance-sheet total — the share of the assets financed by debt rather than equity.
Profit relative to debt — the ability to create earnings while operating with debt.
EBITDA relative to debt — how much operating earnings are available to service the debt.
The ability to pay the interest on the company's debt out of its earnings.
Financial expenses relative to total liabilities — the effective interest rate the company pays on its debt.
The return on assets minus the interest rate on debt. Positive means the company benefits from operating with debt; negative means the debt makes it worse off.
Debt relative to equity — the company's leverage. A higher value means heavier reliance on debt financing.
Total liabilities relative to equity — whether the company operates primarily on borrowed capital or on its own.
Total equity relative to the capital the owners contributed — how the equity has developed from its starting point.
The size of this year's increase or decrease in the company's debt.
Revenue relative to total assets — the ability to generate revenue from the asset base.
Revenue relative to inventory — how many times a year the inventory is sold and replaced. A low value can indicate weak sales or excess inventory.
The size of this year's increase or decrease in the company's equity.
| Name | Role | Member since |
|---|
HS Management | Management | 2014 – 2014 |
JC Management | Management | 2010 – 2011 |
TJ Management | Management | 2011 – 2013 |
JB Management | Management | 2000 – 2000 |
PF Management | Management | 2000 – 2010 |
JE Management | Management | 2013 – 2014 |
| Name | Role | Member since |
|---|
HS Chairman | Chairman | 2005 – 2010 |
JC Board of Directors | Board of Directors | 2010 – 2011 |
PM Chairman | Chairman | 2010 – 2013 |
ÓT Board of Directors | Board of Directors | 2014 – 2014 |
DV Board of Directors | Board of Directors | 2013 – 2014 |
TJ Board of Directors | Board of Directors | 2011 – 2013 |
CL Deputy Chairman | Deputy Chairman | 2005 – 2009 |
PF Board of Directors | Board of Directors | 2000 – 2010 |
BG Chairman | Chairman | 2013 – 2013 |
FA Chairman | Chairman | 2013 – 2014 |
DA Board of Directors | Board of Directors | 2010 – 2013 |
HB Board of Directors | Board of Directors | 2013 – 2014 |
JE Board of Directors | Board of Directors | 2013 – 2014 |
MC Board of Directors | Board of Directors | 2000 – 2010 |
No shareholder data available.
| Person | Role here | Other companies |
|---|---|---|
| Henriette Sidenius | Management | 5 companies |
| Per Finn Lange | Management | 1 company |
| Helena Bergström | Board of Directors | 1 company |